Market Cap

Revance Therapeutics, Inc. Market Capitalization:

$381.0 Million

USD as of Jan. 1, 2025

business Revance Therapeutics, Inc. Company Profile

Revance Therapeutics, Inc. Main Stock Listing

NASDAQ: RVNC

Market Capitalization History of Revance Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Revance Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $381.0 M -48.04%
Jan. 1, 2024 $733.2 M -68.37%
Jan. 1, 2023 $2.32 B 102.32%
Jan. 1, 2022 $1.15 B -47.60%
Jan. 1, 2021 $2.19 B 13.72%
Jan. 1, 2020 $1.92 B 29.53%
Jan. 1, 2019 $1.48 B -46.53%
Jan. 1, 2018 $2.78 B 61.50%
Jan. 1, 2017 $1.72 B -3.52%
Jan. 1, 2016 $1.78 B 28.76%
Jan. 1, 2015 $1.38 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Stocks & Indices

Revance Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: RVNC

Stock: FSX: RTI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.